NuVasive

Rank: 73
2015 Rank78
Employees1,600
Revenue:$811,113,000
R&D Spend:$35,851,000
Fiscal year ending:12-31-15
Click here to see all 100

NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the launch of its Integrated Global Alignment (iGA) platform. - See more at: http://www.nuvasive.com/about-us/newsroom/#sthash.051QkkuH.dpuf

NuVasive Launches Next Generation Biologics Technology. NuVasive Announces Regulatory Approval of Reline Posterior Fixation Technology in Japan. NuVasive to Acquire Ellipse Technologies. NuVasive Receives First Ever FDA 510(k) Clearance of Cervical Corpectomy Cage. NuVasive(R) Reaches Agreement in Principle to Settle OIG Matter.

2015 Top 500 Solar Contractors Key Personnel: Gregory Lucier, Chairman & CEO; Patrick Miles, President and COO; Matt Link, President, Sales; Quentin Blackford, EVP & CFO; Jason Hannon, EVP, International Sales; Carol Cox, EVP, PR & Marketing; Pete Leddy, EVP, HR; Johnson Lai, CIO; Ed Roschak, EVP.;

7475 Lusk Blvd.
San Diego, California
92121
USA